#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infertility male Wolfram syndrome Emphysema Thalassaemia alpha Precursor T-lymphoblastic lymphoma/leukaemia recurrent Restless legs syndrome Fusarium infection Acute myeloid leukaemia (in remission) Encephalitis autoimmune Follicular lymphoma stage I Lymphoma Anaplastic large cell lymphoma T- and null-cell types Progressive supranuclear palsy Immune-mediated myasthenia gravis Malignant glioma More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome Encephalitis autoimmune – Diagnostics Rhabdomyosarcoma – Life with Disease Hyperoxaluria Gastrointestinal stromal tumour – Trials in Disease Choroid melanoma Undifferentiated sarcoma Biotinidase deficiency – Basic Information Behcet’s syndrome Systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IMELASOMERAN [18F]CPFPX Izorlisib Mesilate ANERATRIGINE MESILATE Vonafexor Microcrystalline Cellulose Hmb-001 BLEXIMENIB Valproate Semisodium CHOLINE ALFOSCERATE Psma-11 Resmetirom NADOFARAGENE FIRADENOVEC Insulin Human (Rdna) Latozinemab Immunoglobulins, Normal Human Concizumab Bnt314 GSK4524101A GSK3862995B More therapies…

    Learn about Your Condition

    Patent ductus arteriosus Urticaria cholinergic Melanoma recurrent Ovarian cancer Langerhans cell sarcoma Cholangiosarcoma Deep vein thrombosis Sickle cell anaemia Rosai-Dorfman syndrome Basal cell naevus syndrome Acute on chronic liver failure Viral myocarditis Erdheim-Chester disease Idiopathic pulmonary fibrosis Small fibre neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Saccharomyces Boulardii Cncm I-745 Lyophilized
    • Amoxicillin
    Czechia Lithuania Slovakia Slovenia

  • Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Deep vein thrombosis postoperative
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Rosuvastatin Calcium
    France Norway

  • Study on Acalabrutinib and Obinutuzumab vs. Venetoclax and Obinutuzumab for Newly Diagnosed Chronic Lymphocytic Leukemia Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Poland

  • Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Zenocutuzumab
    Austria Belgium Denmark France Germany Italy +4

  • Comparison of Carvedilol and Flecainide Treatment in Patients with Idiopathic Ventricular Arrhythmias

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ventricular tachycardia
    • Ventricular extrasystoles
    Investigated Drugs:
    • Carvedilol
    • Flecainide
    Spain

  • Study on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Germany Poland Romania Spain
Previous Page
1 … 459 460 461 462 463 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!